HEADER ONCOPROTEIN/IMMUNE SYSTEM 18-MAR-25 9NTQ TITLE IDENTIFICATION AND NON-CLINICAL CHARACTERIZATION OF SAR444200, A NOVEL TITLE 2 ANTI-GPC3 T-CELL ENGAGER, FOR THE TREATMENT OF GPC3+ SOLID TUMORS CAVEAT 9NTQ RESIDUES ALA A 114 AND PHE A 115 THAT ARE NEXT TO EACH OTHER CAVEAT 2 9NTQ IN THE SAMPLE SEQUENCE ARE NOT PROPERLY LINKED. COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYPICAN-3; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: GTR2-2,INTESTINAL PROTEIN OCI-5,MXR7, GPC3; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: A0226015A08; COMPND 8 CHAIN: B; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GPC3, OCI5; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: LAMA GLAMA; SOURCE 11 ORGANISM_COMMON: LLAMA; SOURCE 12 ORGANISM_TAXID: 9844; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS GRIPS, ONCOPROTEIN-IMMUNE SYSTEM COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR J.D.BATCHELOR,E.SVIDRITSKIY REVDAT 1 15-OCT-25 9NTQ 0 JRNL AUTH P.MEONI,A.P.B.VINTEM,V.F.CORTEZ-RETAMOZO,J.JACOBS, JRNL AUTH 2 E.DE TAVERNIER,P.FIORENTINI,D.VAN HOORICK,J.D.BATCHELOR, JRNL AUTH 3 E.SVIDRITSKIY,Y.QIU,E.DEJONCKHEERE,A.LI,L.I.PAO,M.A.BUYSE JRNL TITL IDENTIFICATION AND NON-CLINICAL CHARACTERIZATION OF JRNL TITL 2 SAR444200, A NOVEL ANTI-GPC3 NANOBODY® T-CELL ENGAGER, JRNL TITL 3 FOR THE TREATMENT OF GPC3+ SOLID TUMORS. JRNL REF MOL.CANCER THER. 2025 JRNL REFN ESSN 1538-8514 JRNL PMID 41041827 JRNL DOI 10.1158/1535-7163.MCT-24-1049 REMARK 2 REMARK 2 RESOLUTION. 4.04 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 4.040 REMARK 3 NUMBER OF PARTICLES : 88803 REMARK 3 CTF CORRECTION METHOD : NONE REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9NTQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-MAR-25. REMARK 100 THE DEPOSITION ID IS D_1000294225. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : 2D ARRAY REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : GPC3_A0026015A08 COMPLEX REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : GATAN K2 IS (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 8000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 40 REMARK 465 PHE A 41 REMARK 465 PHE A 42 REMARK 465 GLN A 43 REMARK 465 ARG A 44 REMARK 465 LEU A 45 REMARK 465 GLN A 46 REMARK 465 PRO A 47 REMARK 465 GLY A 48 REMARK 465 LEU A 49 REMARK 465 LYS A 50 REMARK 465 TRP A 51 REMARK 465 VAL A 52 REMARK 465 PRO A 53 REMARK 465 GLU A 54 REMARK 465 THR A 55 REMARK 465 PRO A 56 REMARK 465 VAL A 57 REMARK 465 PRO A 58 REMARK 465 LEU A 187 REMARK 465 PRO A 188 REMARK 465 ASP A 189 REMARK 465 SER A 190 REMARK 465 ALA A 191 REMARK 465 ILE A 228 REMARK 465 PHE A 229 REMARK 465 TYR A 299 REMARK 465 ASN A 308 REMARK 465 TYR A 311 REMARK 465 ARG A 312 REMARK 465 ILE A 313 REMARK 465 TYR A 314 REMARK 465 SER A 330 REMARK 465 ALA A 350 REMARK 465 HIS A 351 REMARK 465 SER A 352 REMARK 465 GLN A 353 REMARK 465 GLN A 354 REMARK 465 ARG A 355 REMARK 465 GLN A 356 REMARK 465 TYR A 357 REMARK 465 ARG A 358 REMARK 465 SER A 359 REMARK 465 ALA A 360 REMARK 465 TYR A 361 REMARK 465 TYR A 362 REMARK 465 PRO A 363 REMARK 465 GLU A 364 REMARK 465 ASP A 365 REMARK 465 LEU A 366 REMARK 465 PHE A 367 REMARK 465 ILE A 368 REMARK 465 ASP A 369 REMARK 465 LYS A 370 REMARK 465 LYS A 371 REMARK 465 VAL A 372 REMARK 465 LEU A 373 REMARK 465 LYS A 374 REMARK 465 VAL A 375 REMARK 465 ALA A 376 REMARK 465 HIS A 377 REMARK 465 VAL A 378 REMARK 465 GLU A 379 REMARK 465 HIS A 380 REMARK 465 GLU A 381 REMARK 465 GLU A 382 REMARK 465 LYS A 435 REMARK 465 ALA A 436 REMARK 465 ALA A 437 REMARK 465 ARG A 438 REMARK 465 ASN A 439 REMARK 465 GLY A 440 REMARK 465 MET A 441 REMARK 465 LYS A 442 REMARK 465 ASN A 443 REMARK 465 GLN A 444 REMARK 465 PHE A 445 REMARK 465 ASN A 446 REMARK 465 LEU A 447 REMARK 465 HIS A 448 REMARK 465 GLU A 449 REMARK 465 LEU A 450 REMARK 465 LYS A 451 REMARK 465 MET A 452 REMARK 465 LYS A 453 REMARK 465 GLY A 454 REMARK 465 PRO A 455 REMARK 465 LYS A 467 REMARK 465 GLN A 471 REMARK 465 ARG A 474 REMARK 465 MET A 476 REMARK 465 UNK B 28 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 39 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 80 CG CD CE NZ REMARK 470 LEU A 192 CG CD1 CD2 REMARK 470 ASP A 193 CG OD1 OD2 REMARK 470 LYS A 221 CG CD CE NZ REMARK 470 LYS A 247 CG CD CE NZ REMARK 470 LYS A 336 CG CD CE NZ REMARK 470 LYS A 347 CG CD CE NZ REMARK 470 ARG A 389 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 431 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 GLN A 218 HA VAL B 107 1.32 REMARK 500 O ALA A 114 N PHE A 115 1.55 REMARK 500 NE2 GLN A 218 CB VAL B 107 1.73 REMARK 500 NE2 GLN A 218 CA VAL B 107 1.81 REMARK 500 NE2 GLN A 218 CG1 VAL B 107 2.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 36 -148.43 -89.05 REMARK 500 SER A 60 125.93 -173.58 REMARK 500 ASP A 61 40.74 -144.82 REMARK 500 VAL A 64 -61.66 -135.85 REMARK 500 GLN A 426 -19.83 -151.55 REMARK 500 SER A 433 -84.45 -95.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-49761 RELATED DB: EMDB REMARK 900 IDENTIFICATION AND NON-CLINICAL CHARACTERIZATION OF SAR444200, A REMARK 900 NOVEL ANTI-GPC3 T-CELL ENGAGER, FOR THE TREATMENT OF GPC3+ SOLID REMARK 900 TUMORS DBREF 9NTQ A 35 477 UNP P51654 GPC3_HUMAN 35 477 DBREF 9NTQ B 1 119 PDB 9NTQ 9NTQ 1 119 SEQRES 1 A 443 CYS HIS GLN VAL ARG SER PHE PHE GLN ARG LEU GLN PRO SEQRES 2 A 443 GLY LEU LYS TRP VAL PRO GLU THR PRO VAL PRO GLY SER SEQRES 3 A 443 ASP LEU GLN VAL CYS LEU PRO LYS GLY PRO THR CYS CYS SEQRES 4 A 443 SER ARG LYS MET GLU GLU LYS TYR GLN LEU THR ALA ARG SEQRES 5 A 443 LEU ASN MET GLU GLN LEU LEU GLN SER ALA SER MET GLU SEQRES 6 A 443 LEU LYS PHE LEU ILE ILE GLN ASN ALA ALA VAL PHE GLN SEQRES 7 A 443 GLU ALA PHE GLU ILE VAL VAL ARG HIS ALA LYS ASN TYR SEQRES 8 A 443 THR ASN ALA MET PHE LYS ASN ASN TYR PRO SER LEU THR SEQRES 9 A 443 PRO GLN ALA PHE GLU PHE VAL GLY GLU PHE PHE THR ASP SEQRES 10 A 443 VAL SER LEU TYR ILE LEU GLY SER ASP ILE ASN VAL ASP SEQRES 11 A 443 ASP MET VAL ASN GLU LEU PHE ASP SER LEU PHE PRO VAL SEQRES 12 A 443 ILE TYR THR GLN LEU MET ASN PRO GLY LEU PRO ASP SER SEQRES 13 A 443 ALA LEU ASP ILE ASN GLU CYS LEU ARG GLY ALA ARG ARG SEQRES 14 A 443 ASP LEU LYS VAL PHE GLY ASN PHE PRO LYS LEU ILE MET SEQRES 15 A 443 THR GLN VAL SER LYS SER LEU GLN VAL THR ARG ILE PHE SEQRES 16 A 443 LEU GLN ALA LEU ASN LEU GLY ILE GLU VAL ILE ASN THR SEQRES 17 A 443 THR ASP HIS LEU LYS PHE SER LYS ASP CYS GLY ARG MET SEQRES 18 A 443 LEU THR ARG MET TRP TYR CYS SER TYR CYS GLN GLY LEU SEQRES 19 A 443 MET MET VAL LYS PRO CYS GLY GLY TYR CYS ASN VAL VAL SEQRES 20 A 443 MET GLN GLY CYS MET ALA GLY VAL VAL GLU ILE ASP LYS SEQRES 21 A 443 TYR TRP ARG GLU TYR ILE LEU SER LEU GLU GLU LEU VAL SEQRES 22 A 443 ASN GLY MET TYR ARG ILE TYR ASP MET GLU ASN VAL LEU SEQRES 23 A 443 LEU GLY LEU PHE SER THR ILE HIS ASP SER ILE GLN TYR SEQRES 24 A 443 VAL GLN LYS ASN ALA GLY LYS LEU THR THR THR ILE GLY SEQRES 25 A 443 LYS LEU CYS ALA HIS SER GLN GLN ARG GLN TYR ARG SER SEQRES 26 A 443 ALA TYR TYR PRO GLU ASP LEU PHE ILE ASP LYS LYS VAL SEQRES 27 A 443 LEU LYS VAL ALA HIS VAL GLU HIS GLU GLU THR LEU SER SEQRES 28 A 443 SER ARG ARG ARG GLU LEU ILE GLN LYS LEU LYS SER PHE SEQRES 29 A 443 ILE SER PHE TYR SER ALA LEU PRO GLY TYR ILE CYS SER SEQRES 30 A 443 HIS SER PRO VAL ALA GLU ASN ASP THR LEU CYS TRP ASN SEQRES 31 A 443 GLY GLN GLU LEU VAL GLU ARG TYR SER GLN LYS ALA ALA SEQRES 32 A 443 ARG ASN GLY MET LYS ASN GLN PHE ASN LEU HIS GLU LEU SEQRES 33 A 443 LYS MET LYS GLY PRO GLU PRO VAL VAL SER GLN ILE ILE SEQRES 34 A 443 ASP LYS LEU LYS HIS ILE ASN GLN LEU LEU ARG THR MET SEQRES 35 A 443 SER SEQRES 1 B 119 ASP VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 B 119 PRO GLY GLY SER LEU ARG LEU SER CYS VAL ALA SER GLY SEQRES 3 B 119 SER UNK PHE ARG SER VAL PHE SER SER SER THR MET GLU SEQRES 4 B 119 TRP TYR ARG GLN PRO PRO GLY LYS LYS ARG GLU LEU VAL SEQRES 5 B 119 ALA ARG ILE ALA PRO GLY ASP GLY THR ASN TYR GLY ALA SEQRES 6 B 119 LEU TYR ALA ASP SER VAL LYS GLY ARG PHE THR ILE SER SEQRES 7 B 119 ARG ASP ASP ALA LYS LYS THR VAL ASP LEU GLN MET ASN SEQRES 8 B 119 SER LEU LYS PRO GLU ASP THR GLY VAL TYR PHE CYS ALA SEQRES 9 B 119 SER GLY VAL ALA TRP GLY GLN GLY THR LEU VAL THR VAL SEQRES 10 B 119 SER SER HET NAG A 501 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG C8 H15 N O6 HELIX 1 AA1 SER A 74 ALA A 114 1 41 HELIX 2 AA2 PHE A 115 TYR A 134 1 20 HELIX 3 AA3 PRO A 135 THR A 138 5 4 HELIX 4 AA4 PRO A 139 LEU A 157 1 19 HELIX 5 AA5 ASN A 162 LEU A 182 1 21 HELIX 6 AA6 ILE A 194 LEU A 205 1 12 HELIX 7 AA7 ASN A 210 ARG A 227 1 18 HELIX 8 AA8 GLN A 231 ASP A 244 1 14 HELIX 9 AA9 SER A 249 TYR A 261 1 13 HELIX 10 AB1 TYR A 261 GLN A 266 1 6 HELIX 11 AB2 CYS A 274 MET A 286 1 13 HELIX 12 AB3 MET A 286 GLU A 291 1 6 HELIX 13 AB4 GLU A 291 GLU A 298 1 8 HELIX 14 AB5 LEU A 301 VAL A 307 1 7 HELIX 15 AB6 MET A 316 GLY A 322 1 7 HELIX 16 AB7 GLY A 322 ASP A 329 1 8 HELIX 17 AB8 GLN A 332 LYS A 336 1 5 HELIX 18 AB9 ASN A 337 CYS A 349 1 13 HELIX 19 AC1 LEU A 384 SER A 397 1 14 HELIX 20 AC2 ALA A 404 HIS A 412 1 9 HELIX 21 AC3 PRO A 457 LEU A 466 1 10 HELIX 22 AC4 HIS A 468 ASN A 470 5 3 HELIX 23 AC5 GLY B 26 SER B 27 5 2 HELIX 24 AC6 PHE B 29 SER B 31 5 3 HELIX 25 AC7 VAL B 32 SER B 36 5 5 HELIX 26 AC8 ASP B 69 LYS B 72 5 4 HELIX 27 AC9 LYS B 94 THR B 98 5 5 SHEET 1 AA1 2 THR A 420 TRP A 423 0 SHEET 2 AA1 2 LEU A 428 ARG A 431 -1 O VAL A 429 N CYS A 422 SHEET 1 AA2 4 GLN B 3 SER B 7 0 SHEET 2 AA2 4 LEU B 18 SER B 25 -1 O SER B 25 N GLN B 3 SHEET 3 AA2 4 THR B 85 MET B 90 -1 O MET B 90 N LEU B 18 SHEET 4 AA2 4 PHE B 75 ASP B 80 -1 N THR B 76 O GLN B 89 SHEET 1 AA3 6 GLY B 10 VAL B 12 0 SHEET 2 AA3 6 THR B 113 VAL B 117 1 O THR B 116 N GLY B 10 SHEET 3 AA3 6 GLY B 99 SER B 105 -1 N TYR B 101 O THR B 113 SHEET 4 AA3 6 MET B 38 GLN B 43 -1 N TYR B 41 O PHE B 102 SHEET 5 AA3 6 GLU B 50 ILE B 55 -1 O ALA B 53 N TRP B 40 SHEET 6 AA3 6 ALA B 65 TYR B 67 -1 O LEU B 66 N ARG B 54 SSBOND 1 CYS A 35 CYS A 72 1555 1555 2.03 SSBOND 2 CYS A 65 CYS A 262 1555 1555 2.03 SSBOND 3 CYS A 73 CYS A 265 1555 1555 2.03 SSBOND 4 CYS A 197 CYS A 349 1555 1555 2.03 SSBOND 5 CYS A 252 CYS A 285 1555 1555 2.03 SSBOND 6 CYS A 274 CYS A 422 1555 1555 2.03 SSBOND 7 CYS A 278 CYS A 410 1555 1555 2.03 SSBOND 8 CYS B 22 CYS B 103 1555 1555 2.02 LINK ND2 ASN A 124 C1 NAG A 501 1555 1555 1.44 CISPEP 1 THR A 138 PRO A 139 0 4.64 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 TER 2755 SER A 477 TER 4501 SER B 119 HETATM 4502 C1 NAG A 501 191.806 188.531 165.560 1.00160.99 C HETATM 4503 C2 NAG A 501 193.090 189.297 165.309 1.00172.50 C HETATM 4504 C3 NAG A 501 193.283 190.340 166.397 1.00178.85 C HETATM 4505 C4 NAG A 501 192.107 191.301 166.368 1.00181.72 C HETATM 4506 C5 NAG A 501 190.796 190.536 166.542 1.00184.05 C HETATM 4507 C6 NAG A 501 189.587 191.419 166.332 1.00182.48 C HETATM 4508 C7 NAG A 501 195.009 188.417 164.084 1.00159.95 C HETATM 4509 C8 NAG A 501 194.555 189.286 162.968 1.00162.91 C HETATM 4510 N2 NAG A 501 194.258 188.444 165.183 1.00165.98 N HETATM 4511 O3 NAG A 501 194.510 191.031 166.185 1.00192.68 O HETATM 4512 O4 NAG A 501 192.226 192.258 167.414 1.00195.79 O HETATM 4513 O5 NAG A 501 190.690 189.458 165.592 1.00176.98 O HETATM 4514 O6 NAG A 501 189.601 192.532 167.214 1.00172.69 O HETATM 4515 O7 NAG A 501 196.002 187.715 163.996 1.00173.02 O CONECT 6 133 CONECT 85 1597 CONECT 133 6 CONECT 139 1621 CONECT 554 4502 CONECT 1095 2202 CONECT 1508 1762 CONECT 1597 85 CONECT 1621 139 CONECT 1687 2513 CONECT 1713 2426 CONECT 1762 1508 CONECT 2202 1095 CONECT 2426 1713 CONECT 2513 1687 CONECT 3054 4285 CONECT 4285 3054 CONECT 4502 554 4503 4513 CONECT 4503 4502 4504 4510 CONECT 4504 4503 4505 4511 CONECT 4505 4504 4506 4512 CONECT 4506 4505 4507 4513 CONECT 4507 4506 4514 CONECT 4508 4509 4510 4515 CONECT 4509 4508 CONECT 4510 4503 4508 CONECT 4511 4504 CONECT 4512 4505 CONECT 4513 4502 4506 CONECT 4514 4507 CONECT 4515 4508 MASTER 250 0 1 27 12 0 0 6 3647 2 31 45 END